TNF and hyperlipidemia: Specifically, systemic exposure to infectious challenges such as bacterial lipopolysaccharide can result in the release of inflammatory cytokines including interleukin-1 (IL-1) and tumour necrosis factor alpha (TNF-α) that alter fat metabolism and promote hyperlipidaemia.